-
Lessons from CAR-T-cell therapy for GD2-positive melanomas Tessa Gargett
-
Immunotherapy combinations - which and why Tara Mitchell
-
Biology and implications of immunotherapy toxicities Rosalie Stephens
-
Debate Surgery is the optimal management for oligo metastatic disease Jonathan Zager
-
Debate Surgery has no role for oligo-metastatic disease Andrew Haydon
-
Debate Radiation for oligometastatic disease should be offered regardless! Rohan Nair
-
Dermoscopic Subtypes of benign naevi and their significance Peter Soyer
-
Long and short term sequential dermoscopy Amanda Oakley
-
When should I refer for confocal microscopy Caterina Longo
-
Dermoscopy of Melanocytic lesions of Acral sites and the Nail Apparatus Alex Chamberlain
-
Diagnosis of amelanotic melanoma with dermoscopy Pascale Guitera
-
Predicting patient outcomes Richard Scolyer
-
Where to next with targeted therapies Georgina Long
-
The potential of CDK4 inhibition in anti-melanoma therapy Karen Shepperd
-
Targeting pro-survival BCL-2 proteins for the treatment of melanoma Marco Herold
-
Repurposing epigenetic drugs to prime for immunotherapy Nikola Bowden
-
Survivorship issues for patients with melanoma and other cancers Michael Jefford
-
Living beyond melanoma is the fear different when you face recurrence or progression Haryana Dhillon
-
Survivorship issues faced by patients with early stage melanoma Donna Milne
-
Not another one! - Monitoring for secondary primary melanomas Yan Pan
-
Interpreting the pathology report for optimal management Catriona McLean
-
Approaches to biopsy of suspicious lesions Victoria Mar
-
Update on excision margins and practical aspects of melanoma surgery Angela Webb
-
Uses and biology of circulating melanoma cells Mel Ziman
